Aarti Drugs Limited (BOM:524348)
365.00
+5.80 (1.61%)
At close: Apr 23, 2025
Aarti Drugs Revenue
Aarti Drugs had revenue of 5.57B INR in the quarter ending December 31, 2024, a decrease of -8.14%. This brings the company's revenue in the last twelve months to 23.30B, down -12.10% year-over-year. In the fiscal year ending March 31, 2024, Aarti Drugs had annual revenue of 25.29B, down -6.90%.
Revenue (ttm)
23.30B
Revenue Growth
-12.10%
P/S Ratio
1.44
Revenue / Employee
21.90M
Employees
1,064
Market Cap
33.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 25.29B | -1.87B | -6.90% |
Mar 31, 2023 | 27.16B | 2.27B | 9.14% |
Mar 31, 2022 | 24.89B | 3.34B | 15.49% |
Mar 31, 2021 | 21.55B | 3.49B | 19.31% |
Mar 31, 2020 | 18.06B | 2.45B | 15.71% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,409.52B |
Infosys | 1,647.16B |
Bajaj Finance | 358.05B |
Aarti Drugs News
- 2 months ago - Aarti Drugs receives US FDA clearance, removed from Import Alert 66-40 - Business Upturn
- 2 months ago - Aarti Drugs Ltd (BOM:524348) Q3 2025 Earnings Call Highlights: Navigating Revenue Decline with ... - GuruFocus
- 3 months ago - Aarti Drugs shares surge despite Q3 FY25 EBITDA margin falls to 11.1% - Business Upturn
- 3 months ago - Aarti Drugs Q3 FY25 results: Revenue down 8% to Rs 556.6 crore, Net Profit flat at Rs 37.09 crore - Business Upturn
- 4 months ago - Aarti Drugs shares surge 15% after receiving EIR from USFDA for API plant in Tarapur - Business Upturn
- 7 months ago - Aarti Drugs shares surge over 2% after arm gets GMP certificate from UK MHRA - Business Upturn
- 7 months ago - Aarti Drugs’ subsidiary Pinnacle Life Science receives GMP certificate from UK MHRA - Business Upturn
- 8 months ago - Aarti Drugs Buyback Opens Today, Set to Close on 18th September 2024 - Business Upturn